Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3393010 | 0.62 | CALM1 (0.44) | ALDH1A1TSHRTDP1CALM1 | |
| SCHEMBL1923108 | 0.56 | CALM1 (0.58) | ALDH1A1CYP3A4TSHRCALM1 | |
| SCHEMBL19102829 | 0.54 | CALM1 (0.55) | ALDH1A1CYP3A4TSHRCALM1 | |
| SCHEMBL8094422 | 0.52 | CALM1 (0.92) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL972712 | 0.52 | CALM1 (0.92) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL6314683 | 0.50 | HRH3 (0.65) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL15071844 | 0.50 | ALDH1A1 (0.47) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| 4,4'-Methylenedianiline SCHEMBL28001 | 0.50 | CYP3A4 (1.00) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL746708 | 0.50 | ALDH1A1 (0.47) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL3334615 | 0.50 | CYP2A6 (0.57) | ESR1ESR2ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040723-A | Curable composition, cured film, organic EL element, and method for producing same | JSR株式会社 | 2025-05-27 | — | — | CN | disclosed |